Shufro Rose & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,100
Closed -$261K 319
2022
Q4
$261K Hold
1,100
0.02% 260
2022
Q3
$220K Buy
+1,100
New +$220K 0.02% 263